New HIV vaccine shows unprecedented success in preclinical study
HIV vaccinepreclinical studynon-human primatesHIV-neutralizing antibodiesLa Jolla Institute for ImmunologyScripps Research.
Author: codebyaditya
Date: 7/28/2026
Article Summary:
Scientists at La Jolla Institute for Immunology and Scripps Research have developed a new HIV vaccine that shows unprecedented success in preclinical studies, prompting the body's immune system to make substantial numbers of HIV-neutralizing antibodies in non-human primates.